AXA FRAMLINGTON BIOTECH FUND

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

Jurisdiction: GBLegal Form: 8888

ACTIVE

LEI: 2138003S7OCTPN98LK47

Summary

AXA FRAMLINGTON BIOTECH FUND is an organization. It is a subsidiary of AXA.

Legal entity: GLEIF